For decades, Nepal was characterized in medical
literature as a region primarily battling severe iodine deficiency, which often
manifested as visible goitres and developmental cretinism. However, recent data
from multidisciplinary hospitals suggest a significant shift in the nation's
endocrine health profile. While universal salt iodization has largely been a
success, a new and more subtle challenge has emerged: subclinical thyroid
dysfunction. A major study recently published by Arun Bahadur Chand and colleagues
at KIST Medical College and Teaching Hospital provides a modern snapshot of
this crisis, revealing that nearly one in five patients seeking care in Central
Nepal suffers from thyroid-related issues. This report synthesizes their
findings with other tertiary care data to outline the current prevalence,
gender disparities, and broader health implications of thyroid disorders in the
region.
The Scale of Dysfunction in Central Nepal
The study conducted by Chand et al. between 2021 and
2024 involved a massive sample size of 13,115 individuals, making it one of the
most comprehensive retrospective analyses in recent years. Their results showed
an overall thyroid dysfunction prevalence of 19.16%. This figure, while
significant, is actually lower than some earlier hospital-based studies. For
instance, research conducted at Tribhuvan University Teaching Hospital (TUTH)
by Mahato in 2015 reported a prevalence of 29%. Similarly, other hospital-based
cross-sectional studies have reported prevalence rates as high as 36%. These
variations may be attributed to differences in geography, ethnic backgrounds,
and the specific patient populations being screened, but they all point toward
a consistent burden that far exceeds the community-based prevalence of
approximately 4.3%.
A critical takeaway from the Chand et al. research is
the dominance of subclinical hypothyroidism, which accounted for nearly
three-fourths of all diagnosed cases, or 13.91% of the total study population.
Subclinical hypothyroidism is defined by elevated thyroid-stimulating hormone
(TSH) levels while the actual thyroid hormones (T3 and T4) remain within the
normal range. Because the symptoms are often mild or non-specific, such as
slight fatigue or weight changes, many patients remain undiagnosed for long periods.
Other conditions identified in the study included subclinical hyperthyroidism
at 3.12%, overt hyperthyroidism at 1.14%, and overt hypothyroidism at 0.99%.
Gender Disparities and Biological
Vulnerability
One of the most consistent findings across all
Nepalese thyroid research is the overwhelming vulnerability of women. Chand et
al. noted a female-to-male ratio of 3:1, with women making up 14.40% of all
cases compared to a much smaller percentage of men. Other studies have seen
even more dramatic divides, with some reporting that women are 5 to 20 times
more likely than men to develop these conditions.
Several biological reasons explain this disparity.
Experts suggest that estrogen plays a vital role in thyroid growth and immune
system activation. High levels of estrogen can increase immunological
responses, which in turn raises the risk of autoimmune diseases like
Hashimoto’s thyroiditis and Graves’ disease. Furthermore, life stages unique to
women, such as pregnancy and menopause, create additional stress on the
thyroid. For example, during pregnancy, there are increased requirements for
thyroid hormones and shifts in immune regulation, which can trigger postpartum
thyroiditis.
The impact on women's health extends to reproductive
function. A study conducted at Kathmandu Medical College found that 27.77% of
women of reproductive age who suffered from abnormal uterine bleeding also had
an underlying thyroid disorder. Of these women, the vast majority had
hypothyroidism, which is known to cause heavy menstrual flow or menorrhagia.
This suggests that many gynecological complaints in Nepal may actually be
secondary symptoms of an untreated thyroid problem.
Age-Related Trends and Pediatric Concerns
While thyroid disorders are most prevalent among
adults aged 18 to 59, the risk profile changes throughout the human lifespan.
Chand et al. found that approximately 79% of their patients with dysfunction
fell into this adult age bracket. However, the elderly are also highly
susceptible. In their sample, 24% of participants aged 60 to 69 were affected,
highlighting a trend where the incidence of thyroid issues often increases with
age.
Interestingly, the burden is not absent in younger
populations. Chand et al. reported that 22.6% of children aged 1 to 9 in their
study showed signs of dysfunction. Earlier data from Mahato suggested that
hypothyroidism in children is particularly concerning because it can lead to
stunted physical growth and delayed mental development. This
"cradle-to-grave" prevalence emphasizes that thyroid screening should
not be restricted only to middle-aged adults.
The Shifting Etiology: From Iodine Lack to
Autoimmunity
Nepal's history with iodine is complex. While the
nation has successfully implemented salt iodization to combat deficiency, some
areas are now reaching a state of iodine excess. This is a double-edged sword
because while adequate iodine is necessary for hormone production, excessive
amounts can trigger autoimmune reactions.
A hospital-based study in Central Nepal found that 75%
of patients with subclinical thyroid disorders tested positive for thyroid
autoantibodies. This indicates that the body's own immune system is attacking
the thyroid gland, often leading to chronic conditions like Hashimoto's
thyroiditis. The researchers noted that simply addressing iodine deficiency
through salt is no longer sufficient; there is now a pressing need to monitor
the rise of autoimmune-driven disease.
Links to Chronic Comorbidities and
Cardiovascular Risks
The implications of thyroid dysfunction go far beyond
the thyroid gland itself. Thyroid hormones are the primary regulators of
metabolism, and when they are out of balance, they affect every other organ
system.
For instance, there is a strong correlation between
thyroid health and diabetes. Research among Nepalese diabetic patients revealed
a thyroid dysfunction prevalence of 36.03%. These patients often exhibit higher
levels of total cholesterol and LDL (bad) cholesterol, which significantly
increases their risk of heart disease. Furthermore, postmenopausal women with
thyroid issues were frequently found to be in the overweight or obese
categories, suggesting a cyclical link where obesity disrupts endocrine function
and a sluggish thyroid makes weight management more difficult.
Perhaps the most alarming "hidden" risk is
cardiovascular. A study at a university teaching hospital in Central Nepal
examined "QT dispersion" in the hearts of women with subclinical
hypothyroidism. QT dispersion is a measure used on an ECG to predict the risk
of irregular heartbeats or arrhythmias. The researchers found that even women
with mild thyroid issues had significantly prolonged QT dispersion, suggesting
they are at a higher risk for malignant arrhythmias and sudden cardiac death.
This evidence proves that even "subclinical" cases, which are often
dismissed as minor, can have life-threatening consequences if left unmonitored.
Conclusion and Recommendations for Public
Health
The findings from KIST Medical College, along with
supporting data from TUTH and other institutions, clearly demonstrate that
Central Nepal is facing a significant and evolving endocrine health challenge.
The high prevalence of subclinical disorders, especially among women and the
elderly, suggests that a large portion of the population may be living with
undiagnosed conditions that quietly increase their risk of heart disease,
metabolic disorders, and reproductive complications.
The researchers conclude that routine screening for
thyroid function should become a standard part of medical check-ups in Nepal,
particularly for high-risk groups. Early detection through simple blood tests
for TSH, T3, and T4 can prevent the progression to overt disease and reduce the
long-term burden on the healthcare system. As Nepal continues to navigate its
transition from a country of iodine deficiency to one of autoimmune and
subclinical thyroid prevalence, public awareness and consistent clinical monitoring
will be the most effective tools for ensuring the wellness of its citizens.
